PT448 – Deborah C. Mash, Ph.D. – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy
Psychedelics Today
Psychedelics Today, LLC
4.6 • 598 Ratings
🗓️ 6 October 2023
⏱️ 52 minutes
🧾️ Download transcript
Summary
In this episode, Joe interviews Deborah C. Mash, Ph.D.: neuroscientist; Professor Emerita of Neurology and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine; and leading researcher in addiction and brain disorders for over 30 years.
She is also the CEO and Founder of DemeRx Inc., a clinical stage drug development company working to advance ibogaine and its active metabolite, noribogaine, for the treatment of opioid use disorder. She talks about the Federal and state complications behind ibogaine research, the need for partnerships between clinics and researchers, what needs to be done to collect much needed Phase II and III ibogaine data, and why this all has to be in partnership with the FDA.
And she discusses much more: her story of how studying Cocaethylene led to her finding out about ibogaine; ibogaine and QTc-prolongation; deaths related to iboga and the amount of variables that aren't considered; how the French were essentially using noribogaine in the 1930s; and, as this was recorded at Psychedelic Science 2023, her thoughts on the event and Rick Doblin's opening statement.
Click here to head to the show notes page.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | Hey, it's Joe here letting you know about two new classes coming up that Kyle and I are producing in person. |
| 0:06.7 | So if you're in Miami or near Denver or are willing to travel, check these out. |
| 0:10.7 | So we've been teaching navigating psychedelics for a long time. |
| 0:14.1 | And we decided to come up with a two-day format where you still get all of the online training for navigating psychedelics, but you get two different |
| 0:21.9 | eight-hour class days with us in person. So if you want to check out the Miami dates, it's October |
| 0:28.2 | 7 and 8, and in Denver, November 10 and 11. For Denver, again, November 10 and 11, and that's going to be |
| 0:36.0 | really fun. So check out our website, Psychedelicysday.com slash events. |
| 0:40.2 | If you want to learn more about those classes and hope to see you in class. |
| 0:44.4 | Vital, our 12-month practitioner training program is back for its third cohort starting January |
| 0:50.1 | 2024. |
| 0:51.7 | The last two cohorts have been nothing short of transformational, both personally and |
| 0:56.2 | professionally, for everyone involved, and here's a little taste of what makes it so special. Vital |
| 1:01.8 | is a process-oriented curriculum, focusing on multidisciplinary perspectives and wisdom traditions, |
| 1:08.7 | guiding students through powerful inner work and building practical |
| 1:12.0 | skills to support lifelong growth. Through lectures, study groups, elective modules, retreats, |
| 1:18.6 | and process papers, you'll have all the support you need to develop your own vision and model |
| 1:23.6 | for entering this exciting field. Applications for Vital are open until December the 20th, with early bird discounts available |
| 1:31.4 | until November the 19th. |
| 1:33.3 | We invite you to apply early to improve your chances for being accepted into this global |
| 1:38.2 | community of the next generation of psychedelic wellness practitioners. |
| 1:42.3 | So head to Vitalpsychedictraining.com to download our full course curriculum and learn more about this transformative journey. |
| 1:50.0 | Psychedelics today is excited to introduce you to Homecoming. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Psychedelics Today, LLC, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Psychedelics Today, LLC and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

